Pre-operative staging of invasive breast cancer with MR mammography and/or PET: Boon or bunk?

British Journal of Radiology

Volumn 75, Issue 898, 2002, Pages 789-798

  Rieber, A ^a,b   Schirrmeister, H ^a   Gabelmann, A ^a   Nuessle, K ^a   Reske, S ^a   Kreienberg, R ^a   Brambs, H J ^a   Kuehn, T ^a  

^a UNIVERSITY OF ULM   (Germany)

^b Hospital Munich Neuperlach   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; BREAST CANCER; BREAST CARCINOMA; BREAST TUMOR; CANCER INVASION; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; LYMPH NODE METASTASIS; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING; VALIDATION PROCESS;

EID: 0036775586     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.75.898.750789     Document Type: Article

References (30)

1. Heywang-Koebrunner SH. Contrast-enhanced magnetic resonance imaging of the breast. Invest Radiol 1994;29:94-104.
2. Gilles R, Guinebretiere JM, Meunier M, et al. Nonpalpable breast tumours: diagnosis with contrast-enhanced substraction dynamic MR imaging. Radiology 1994;191:625-31.
3. Kaiser WA. MR mammography. Radiologe 1993:292-8.
4. Gilles R, Zafrani B, Guinebretiere JM, et al. Ductal carcinoma in situ: MR imaging - histopathologic correlation. Radiology 1995;196:415-9.
5. Fischer U, Westerhof JP, Brinck U, et al. The ductal carcinoma in situ in contrast-enhanced dynamic MR mammography. Fortschr Geb Roentgenstr Nuklearmed Erganzungsbd 1996;164:290-4.
6. Heywang SH, Hilbertz T, Beck R, et al. Gd-DTPA enhanced MR imaging of the breast in patients with postoperative scarring and silicon implants. J Comput Assist Tomogr 1990;14:348-56.
7. Morris EA, Schwartz LH, Dershaw DD, et al. MR imaging of the breast in patients with occult primary breast carcinoma. Radiology 1997;205:437-40.
8. Rieber A, Merkle E, Boehm W, et al. MRI of histologically confirmed mammary carcinoma: clinical relevance of diagnostic procedures for detection of multifocal or contralateral secondary carcinoma. J Comput Assist Tomogr 1997;21:773-9.
9. Fischer U, Vosshenrich R, Probs A, et al. Preoperative MR mammography in patients with breast cancer - useful information or useless extravagance? Fortschr Geb Roentgenstr Nuklearmed Erganzungsbd 1994;161:300-6.
10. Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 1999;213:881-8.
11. Avril N, Dose J, Jaenicke F, et al. Metabolic characterization of breast tumours with positron emission tomography using F-18 fluorodeoxyglucose. J Clin Oncol 1996;14:1848-57.
12. Dose J, Avril N, Ziegler S, et al. Ranking of positron emission tomography (PET) with F-18 Fluorodeoxyglucose (FDG) in the diagnosis of carcinomas of the breast. Geburtshilfe Frauenheilkd 1997;57:315-20.
13. Rostom AY, Powe J, Kandil A, et al. Positron emission tomography in breast cancer: a clinicopathological correlation of results. Br J Radiol 1999;72:1064-8.
14. Palmedo H, Bender H, Gruenwald F, et al. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumours. Eur J Nuc Med 1997;24:1138-45.
15. Orel SG, Kay N, Reynolds C, et al. BI-RADS categorization as a predictor of malignancy. Radiology 1999;211L:845-50.
16. Gerhardt P. Recommendations of the Committee of Magnetic Resonance Tomography: Quality Standards for the MRI of the Breast. Annual Report of the German Roentgen Ray Society 1995;43:59-61.
17. Mueller-Schimpfle M, Stoll P, Stern W, et al. Do mammography, sonography and MR mammography have a diagnostic benefit compared with mammography and sonography? AJR 1997;168:1323-9.
18. Audretsch WP. Reconstruction of the partial mastectomy defect: classification and method. In: Spear SL. Surgery of the Breast: principles and art. Philadelphia, PA: Lipincott-Raven, 1998: 155-5.
19. Hathaway PB, Mankoff DA, Maravilla KR, et al. Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience. Radiology 1999;210:807-14.
20. Ruhlmann J, Oehr P, Bender H, et al. PET in daily routine for diagnostics of breast cancer. Acta Med Austriaca 1997;24:63-7.
21. Avril N, Schelling M, Dose J, et al. Utility of PET in breast cancer. Clin Positron Imaging 1999;2:261-71.
22. Harms SE, Flaming DP, Hesley KL, et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 1993;187:493-501.
23. Oellinger H, Heins S, Sander B, et al. Gd-DTPA enhanced MRI of the breast: the most sensitive method for detecting multicentric carcinomas in female breasts? Eur Radiol 1993;3:223-6.
24. Mumtaz H, Hall-Craggs MA, Davidson T, et al. Staging of symptomatic primary breast cancer with MR imaging. AJR 1997;169:417-24.
25. Boetes C, Mus RDM, Holland R, et al. Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 1995;197:743-7.
26. Kramer S, Schulz-Wendtland R, Hagedorn K, et al. Magnetic resonance imaging and its role in the diagnosis of multicentric breast cancer. Anticancer Res 1998;18:2163-4.
27. Crippa F, Agresti R, Seregni E, et al. Prospective evaluation of fluorine-18-FDG-PET in presurgical staging of the axilla in breast cancer. J Nucl Med 1998;39:4-8.
28. Adler LP, Faulhaber PF, Schnur KC, et al. Axillary lymph node metastases: screening with (F-18)2-deoxy-2-fluoro-D-Glucose (FDG) PET. Radiology 1997;203:323-7.
29. Avril N, Dose J, Jaenicke F, et al. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2- (fluorine-18)-fluoro-2-deoxy-D-glucose. J Natl Cancer Inst 1996;88:1204-9.
30. Smith IC, Ogston KN, Whitford P, et al. Staging of the axilla in breast cancer. Ann Surg 1998;228:220-7.